Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP418686.RAtq3I-_Di-LcV_0UK5jIuf75uPSvfMmdHhvqJOy1vwNw130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP418686.RAtq3I-_Di-LcV_0UK5jIuf75uPSvfMmdHhvqJOy1vwNw130_assertion type Assertion NP418686.RAtq3I-_Di-LcV_0UK5jIuf75uPSvfMmdHhvqJOy1vwNw130_head.
- NP418686.RAtq3I-_Di-LcV_0UK5jIuf75uPSvfMmdHhvqJOy1vwNw130_assertion description "[Specifically, chemoprevention trials are currently ongoing to evaluate the efficacy of COX-2 inhibitors in the prevention of colorectal cancer in HNPCC and familial adenomatous polyposis patients.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP418686.RAtq3I-_Di-LcV_0UK5jIuf75uPSvfMmdHhvqJOy1vwNw130_provenance.
- NP418686.RAtq3I-_Di-LcV_0UK5jIuf75uPSvfMmdHhvqJOy1vwNw130_assertion evidence source_evidence_literature NP418686.RAtq3I-_Di-LcV_0UK5jIuf75uPSvfMmdHhvqJOy1vwNw130_provenance.
- NP418686.RAtq3I-_Di-LcV_0UK5jIuf75uPSvfMmdHhvqJOy1vwNw130_assertion SIO_000772 14585257 NP418686.RAtq3I-_Di-LcV_0UK5jIuf75uPSvfMmdHhvqJOy1vwNw130_provenance.
- NP418686.RAtq3I-_Di-LcV_0UK5jIuf75uPSvfMmdHhvqJOy1vwNw130_assertion wasDerivedFrom befree-2016 NP418686.RAtq3I-_Di-LcV_0UK5jIuf75uPSvfMmdHhvqJOy1vwNw130_provenance.
- NP418686.RAtq3I-_Di-LcV_0UK5jIuf75uPSvfMmdHhvqJOy1vwNw130_assertion wasGeneratedBy ECO_0000203 NP418686.RAtq3I-_Di-LcV_0UK5jIuf75uPSvfMmdHhvqJOy1vwNw130_provenance.